Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.1218 per EA under NDC 70010014901. Its NADAC has been published 200 times since Aug 31, 2022.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET
Butalbital, Acetaminophen and CaffeineStrength
325; 50; 40 mg/1; mg/1; mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010014901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA040864On Market Since
6/29/2022
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET has been published 200 times since Aug 31, 2022, and over the history we have for it it has declined 33.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1218 per EA |
|---|---|
| All-time high | $0.1852 (Oct 12, 2022) |
| All-time low | $0.1112 (Nov 20, 2024) |
| 52-week high | $0.1493 |
| 52-week low | $0.1218 |
| Median price | $0.1493 |
| Average price | $0.1473 |
| Largest weekly change | +35.2% (Aug 21, 2024) |
| Weeks tracked | 200 |
| Tracking since | Aug 31, 2022 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET, manufactured by Granules Pharmaceuticals Inc., is $0.1218 per EA (NDC 70010014901), effective Jun 24, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET has declined 33.8%. It has been tracked across 200 weekly CMS publications since Aug 31, 2022.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?
Since Aug 31, 2022, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET has ranged from a low of $0.1112 (Nov 20, 2024) to a high of $0.1852 (Oct 12, 2022), with a median of $0.1493 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET, but none are currently priced below it.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET (NDC 70010014901) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification